<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>San Diego Biotechnology Network: Biotech Events, Jobs, News, Companies, Directory, Blog, &#38; Calendar &#187; San Diego Union Tribune</title>
	<atom:link href="http://sdbn.org/category/sdbiotechnews/san-diego-union-tribune/feed/" rel="self" type="application/rss+xml" />
	<link>http://sdbn.org</link>
	<description>sdbn.org</description>
	<lastBuildDate>Sat, 31 Jul 2010 02:49:17 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=abc</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>WVa plant to cut storage of deadly chemical</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/26/us-bayer-mic-storage-082609/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/26/us-bayer-mic-storage-082609/?business#comments</comments>
		<pubDate>Wed, 26 Aug 2009 18:44:39 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/26/us-bayer-mic-storage-082609/?business</guid>
		<description><![CDATA[	Bayer CropScience said Wednesday that a West Virginia plant will reduce its storage of a toxic chemical that was in danger of being released in a deadly explosion nearly a year ago.

]]></description>
			<content:encoded><![CDATA[
	Bayer CropScience said Wednesday that a West Virginia plant will reduce its storage of a toxic chemical that was in danger of being released in a deadly explosion nearly a year ago.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/26/us-bayer-mic-storage-082609/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dyax receives $1.5 million payment</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/26/us-dyax-payment-082609/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/26/us-dyax-payment-082609/?business#comments</comments>
		<pubDate>Wed, 26 Aug 2009 17:53:01 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/26/us-dyax-payment-082609/?business</guid>
		<description><![CDATA[	Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly &#38; Co. moved a potential leukemia treatment into early-stage clinical trials.

]]></description>
			<content:encoded><![CDATA[
	Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly &amp; Co. moved a potential leukemia treatment into early-stage clinical trials.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/26/us-dyax-payment-082609/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA reports health problems with stolen insulin</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/26/us-stolen-insulin-fda-warning-082609/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/26/us-stolen-insulin-fda-warning-082609/?business#comments</comments>
		<pubDate>Wed, 26 Aug 2009 17:49:25 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/26/us-stolen-insulin-fda-warning-082609/?business</guid>
		<description><![CDATA[	The Food and Drug Administration is warning consumers to avoid certain vials of insulin made by Novo Nordisk that were stolen earlier this year and may not be safe for use.

]]></description>
			<content:encoded><![CDATA[
	The Food and Drug Administration is warning consumers to avoid certain vials of insulin made by Novo Nordisk that were stolen earlier this year and may not be safe for use.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/26/us-stolen-insulin-fda-warning-082609/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISTA says daily Xibrom eye drops met goal in study</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/26/us-ista-pharma-xibrom-082609/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/26/us-ista-pharma-xibrom-082609/?business#comments</comments>
		<pubDate>Wed, 26 Aug 2009 11:31:14 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/26/us-ista-pharma-xibrom-082609/?business</guid>
		<description><![CDATA[	ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug.

]]></description>
			<content:encoded><![CDATA[
	ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/26/us-ista-pharma-xibrom-082609/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amylin board of directors appoints new chairman</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/25/amylin-board-directors-appoints-new-chairman/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/25/amylin-board-directors-appoints-new-chairman/?business#comments</comments>
		<pubDate>Tue, 25 Aug 2009 09:00:00 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/25/amylin-board-directors-appoints-new-chairman/?business</guid>
		<description><![CDATA[	Three months after a contentious proxy battle resulted in the ouster of its chairman, the board of directors at San Diego's Amylin Pharmaceuticals has picked a new chairman: Paulo Costa, who formerly headed the U.S. operations of biotech giant Novartis.

]]></description>
			<content:encoded><![CDATA[
	Three months after a contentious proxy battle resulted in the ouster of its chairman, the board of directors at San Diego's Amylin Pharmaceuticals has picked a new chairman: Paulo Costa, who formerly headed the U.S. operations of biotech giant Novartis.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/25/amylin-board-directors-appoints-new-chairman/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>San Diego-based Ligand agrees to buy Neurogen</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/25/san-diego-based-ligand-agrees-buy-neurogen/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/25/san-diego-based-ligand-agrees-buy-neurogen/?business#comments</comments>
		<pubDate>Tue, 25 Aug 2009 09:00:00 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/25/san-diego-based-ligand-agrees-buy-neurogen/?business</guid>
		<description><![CDATA[	San Diego's Ligand Pharmaceuticals yesterday agreed to buy Neurogen, a Connecticut company that develops drugs for psychiatric and neurological disorders.

]]></description>
			<content:encoded><![CDATA[
	San Diego's Ligand Pharmaceuticals yesterday agreed to buy Neurogen, a Connecticut company that develops drugs for psychiatric and neurological disorders.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/25/san-diego-based-ligand-agrees-buy-neurogen/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Warner Chilcott buying P&amp;G drug business for $3.1B</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/24/us-warner-chilcott-procter-gamble-082409/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/24/us-warner-chilcott-procter-gamble-082409/?business#comments</comments>
		<pubDate>Mon, 24 Aug 2009 22:23:42 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/24/us-warner-chilcott-procter-gamble-082409/?business</guid>
		<description><![CDATA[	Shares of Ireland's Warner Chilcott Plc skyrocketed Monday on news of its bid to morph from a small, specialty pharmaceutical company to a global player by buying Procter &#38; Gamble Co.'s prescription drug business for $3.1 billion.

]]></description>
			<content:encoded><![CDATA[
	Shares of Ireland's Warner Chilcott Plc skyrocketed Monday on news of its bid to morph from a small, specialty pharmaceutical company to a global player by buying Procter &amp; Gamble Co.'s prescription drug business for $3.1 billion.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/24/us-warner-chilcott-procter-gamble-082409/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA probes liver damage with weight loss pill alli</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/24/us-weight-loss-drug-fda-082409/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/24/us-weight-loss-drug-fda-082409/?business#comments</comments>
		<pubDate>Mon, 24 Aug 2009 22:03:36 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/24/us-weight-loss-drug-fda-082409/?business</guid>
		<description><![CDATA[	The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.

]]></description>
			<content:encoded><![CDATA[
	The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/24/us-weight-loss-drug-fda-082409/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biovail will pay up to $192M for Parkinson&#8217;s drug</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/24/us-biovail-parkinsons-drug-082409/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/24/us-biovail-parkinsons-drug-082409/?business#comments</comments>
		<pubDate>Mon, 24 Aug 2009 17:39:15 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/24/us-biovail-parkinsons-drug-082409/?business</guid>
		<description><![CDATA[	Biovail Corp. said Monday it bought a drug intended to treat muscle movements caused by Parkinson's disease drugs, and will pay up to $192 million and potential royalties for the product.

]]></description>
			<content:encoded><![CDATA[
	Biovail Corp. said Monday it bought a drug intended to treat muscle movements caused by Parkinson's disease drugs, and will pay up to $192 million and potential royalties for the product.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/24/us-biovail-parkinsons-drug-082409/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ligand Pharmaceuticals agrees to buy Neurogen</title>
		<link>http://www3.signonsandiego.com/stories/2009/aug/24/ligand-pharmaceuticals-agrees-buy-neurogen/?business</link>
		<comments>http://www3.signonsandiego.com/stories/2009/aug/24/ligand-pharmaceuticals-agrees-buy-neurogen/?business#comments</comments>
		<pubDate>Mon, 24 Aug 2009 17:09:00 +0000</pubDate>
		<dc:creator>Mary Canady</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Union Tribune]]></category>
		<category><![CDATA[Syndication]]></category>

		<guid isPermaLink="false">http://www3.signonsandiego.com/stories/2009/aug/24/ligand-pharmaceuticals-agrees-buy-neurogen/?business</guid>
		<description><![CDATA[	Ligand Pharmaceuticals Inc. said Monday it has agreed to buy Neurogen for $11 million in stock as well as certain future cash payments based on licensing deals, real estate sales and other milestones.

]]></description>
			<content:encoded><![CDATA[
	Ligand Pharmaceuticals Inc. said Monday it has agreed to buy Neurogen for $11 million in stock as well as certain future cash payments based on licensing deals, real estate sales and other milestones.

]]></content:encoded>
			<wfw:commentRss>http://www3.signonsandiego.com/stories/2009/aug/24/ligand-pharmaceuticals-agrees-buy-neurogen/?business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
